A new Japanese ecological study revealed that prefecture-specific participation rates for Specific Health Checkups (SHC participation rates) had significant negative effects on prefecture-specific standardized incidence rates (SIRs) of treated ESKD and prefecture-specific prevalence of chronic kidney disease (CKD).
Cystic fibrosis drug reduces hyper-inflammation in COVID-19 pneumonia patients
A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections,